Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy

被引:24
|
作者
Fried, Terri R. [1 ,2 ,3 ]
Mecca, Marcia C. [1 ,2 ,3 ]
机构
[1] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, 950 Campbell Ave, West Haven, CT 06516 USA
[2] Geriatr & Extended Care, West Haven, CT USA
[3] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
关键词
polypharmacy; medication appropriateness; multimorbidity; POTENTIALLY INAPPROPRIATE; OUTCOMES; ASSOCIATION; VALIDATION; MORTALITY; ADHERENCE; CRITERIA; STOPP; RISK;
D O I
10.1111/jgs.15798
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Older adults are prescribed a growing number of medications. Polypharmacy, commonly considered the receipt of five or more medications, is associated with a range of adverse outcomes. There is a debate about the reason(s) why. On one side is the assertion that older persons are being prescribed too many medications, with the number of medications increasing the risk of adverse events. On the other side is the observation that polypharmacy is associated both with overprescribing of inappropriate medications and underprescribing of appropriate medications. This leads to the concept of "inappropriate" vs "appropriate" polypharmacy, with the latter resulting from the prescription of many correct medications to persons with multiple chronic conditions. Few studies have examined the health outcomes associated with adding and/or removing medications to address this debate directly. The criteria used to identify underutilized medications are based on results of randomized controlled trials that may not be generalizable to older adults. Several randomized controlled trials and many more observational studies provide evidence that these criteria overestimate medication benefits and underestimate harms. In addition, evidence suggests that the marginal effects of medications added to an already complex regimen differ from their effects when considered individually. Although in selected circumstances adding medications results in benefit to patients, patients with multimorbidity and frailty/disability have susceptibilities that can decrease the likelihood of medication benefit and increase the likelihood of harms. The identification of appropriate polypharmacy requires more robust criteria to evaluate the net effects of complex medication regimens.
引用
收藏
页码:1123 / 1127
页数:5
相关论文
共 50 条
  • [1] Addressing Medication Appropriateness and Polypharmacy in Frail Older Adults in Primary Care
    Sadowski, C. A.
    Khera, S.
    Yua, H.
    Abbasi, M.
    Dabravolskai, J.
    Lau, A.
    Parker, K.
    Burns, G.
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2021, 74 (02): : 168 - 168
  • [2] Polypharmacy and Medication Management in Older Adults
    Kim, Jennifer
    Parish, Abby Luck
    [J]. NURSING CLINICS OF NORTH AMERICA, 2017, 52 (03) : 457 - +
  • [3] Screening for Medication Appropriateness in Older Adults
    Zullo, Andrew R.
    Gray, Shelly L.
    Holmes, Holly M.
    Marcum, Zachary A.
    [J]. CLINICS IN GERIATRIC MEDICINE, 2018, 34 (01) : 39 - +
  • [4] Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases
    Bharati Kochar
    Alison Rusher
    Elizabeth Araka
    Rachel Glasser
    Jennifer Lai
    Christine Ritchie
    Ashwin N. Ananthakrishnan
    [J]. Digestive Diseases and Sciences, 2024, 69 : 766 - 774
  • [5] Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases
    Kochar, Bharati
    Rusher, Alison
    Araka, Elizabeth
    Glasser, Rachel
    Lai, Jennifer
    Ritchie, Christine
    Ananthakrishnan, Ashwin N.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (03) : 766 - 774
  • [6] Polypharmacy and medication safety in vulnerable older immigrants with cognitive disorders - a scoping abstract
    Lynnerup, Camilla
    Nielsen, Dorthe
    Sodemann, Morten
    Pottegard, Anton
    Rossing, Charlotte
    Ryg, Jesper
    El-Sour, Mira
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (02) : 815 - 815
  • [7] Profiles of polypharmacy in older adults and medication associations with signs of aspiration
    Pu, Dai
    Wong, Michael C. H.
    Yiu, Edwin M. L.
    Chan, Karen M. K.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (05) : 643 - 649
  • [8] Medication transitions and polypharmacy in older adults following acute care
    Gamble, John-Michael
    Hall, Jill J.
    Marrie, Thomas J.
    Sadowski, Cheryl A.
    Majumdar, Sumit R.
    Eurich, Dean T.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 189 - 196
  • [9] LONG-TERM MEDICATION USE AND POLYPHARMACY IN OLDER ADULTS
    Egici, Memet Taskin
    Bagci, Hasan
    Gurel, Nermin
    [J]. TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2021, 24 (02): : 122 - 133
  • [10] Sources of medication omissions among hospitalized older adults with polypharmacy
    Shah, Avantika Saraf
    Hollingsworth, Emily Kay
    Shotwell, Matthew Stephen
    Mixon, Amanda S.
    Simmons, Sandra Faye
    Vasilevskis, Eduard Eric
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (04) : 1180 - 1189